» Articles » PMID: 2033265

Induction of Protective Immunity to Friend Murine Leukemia Virus in Genetic Nonresponders to Virus Envelope Protein

Overview
Journal J Immunol
Date 1991 Jun 1
PMID 2033265
Citations 16
Authors
Affiliations
Soon will be listed here.
Abstract

(B10.A x A/WySn)F1, H-2a/a, mice are genetic nonresponders to the envelope protein of Friend murine leukemia helper virus (F-MuLV) when immunized with a recombinant vaccinia virus expressing F-MuLV env gene. In contrast these mice can be protectively immunized against leukemogenic Friend virus complex using formalin-fixed F-MuLV virions in CFA. To determine which viral proteins were responsible for this immune protection, virion proteins prepared by SDS-PAGE and electroelution were used to immunize mice. Purified gp70 envelope protein in CFA was capable of inducing strong immune protection against the challenge with Friend virus complex in H-2a/a mice. Immunologic studies demonstrated that immunized mice developed a virus-specific T cell proliferative response and showed IgM to IgG Ig class switching of virus-neutralizing antibodies. These results indicated that genetically controlled immune nonresponsiveness to F-MuLV envelope Ag in H-2a/a mice could be overcome using denatured viral envelope protein together with a strong adjuvant.

Citing Articles

A detailed analysis of F-MuLV- and SFFV-infected cells in Friend virus-infected mice reveals the contribution of both F-MuLV- and SFFV-infected cells to the interleukin-10 host response.

Podschwadt P, Malyshkina A, Windmann S, Werner T, Hansen W, Bayer W Retrovirology. 2022; 19(1):29.

PMID: 36527061 PMC: 9758943. DOI: 10.1186/s12977-022-00613-4.


Immunization with a murine cytomegalovirus based vector encoding retrovirus envelope confers strong protection from Friend retrovirus challenge infection.

Bongard N, Le-Trilling V, Malyshkina A, Ruckborn M, Wohlgemuth K, Wensing I PLoS Pathog. 2019; 15(9):e1008043.

PMID: 31568492 PMC: 6786657. DOI: 10.1371/journal.ppat.1008043.


Interference of retroviral envelope with vaccine-induced CD8 T cell responses is relieved by co-administration of cytokine-encoding vectors.

Bongard N, Lapuente D, Windmann S, Dittmer U, Tenbusch M, Bayer W Retrovirology. 2017; 14(1):28.

PMID: 28449719 PMC: 5408827. DOI: 10.1186/s12977-017-0352-7.


Induction of complex immune responses and strong protection against retrovirus challenge by adenovirus-based immunization depends on the order of vaccine delivery.

Kaulfuss M, Wensing I, Windmann S, Hrycak C, Bayer W Retrovirology. 2017; 14(1):8.

PMID: 28166802 PMC: 5294899. DOI: 10.1186/s12977-017-0336-7.


Class switch recombination and somatic hypermutation of virus-neutralizing antibodies are not essential for control of friend retrovirus infection.

Kato M, Tsuji-Kawahara S, Kawasaki Y, Kinoshita S, Chikaishi T, Takamura S J Virol. 2014; 89(2):1468-73.

PMID: 25378499 PMC: 4300674. DOI: 10.1128/JVI.02293-14.